(97 days)
Not Found
No
The device description and performance studies focus on the mechanical and material properties of a cannula and introducer, with no mention of AI or ML capabilities.
No
A therapeutic device is one that treats a disease or condition. This device, a cannula and introducer, is used to facilitate cannulation and perfusion, and to connect with extracorporeal circulatory support equipment, but it does not directly treat a disease or condition itself. It's a tool used in a medical procedure, not a therapy in itself.
No
Explanation: The device is intended to cannulate vessels, perfuse vessels or organs, and/or connect with accessory extracorporeal circulatory support equipment. It is used for therapeutic or supportive purposes, not for diagnosing a medical condition.
No
The device description clearly details physical components like cannulas, introducers, radiopaque markers, and suture wings, indicating it is a hardware medical device.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health. This testing is done outside of the body.
- Device Function: The description clearly states the device is intended to "cannulate vessels, perfuse vessels or organs and/or connect with accessory extracorporeal circulatory support equipment." This involves direct interaction with the patient's circulatory system within the body.
- Lack of Specimen Analysis: There is no mention of the device being used to analyze samples or provide diagnostic information based on those samples. Its purpose is to facilitate blood flow and support circulation.
The device is a surgical/interventional device used directly on the patient, not for laboratory testing of specimens.
N/A
Intended Use / Indications for Use
The Femoral Arterial Cannula and Introducer is intended to cannulate vessels, perfuse vessels or organs and/or connect with accessory extracorporeal circulatory support equipment for a duration of six hours or less. The cannula introducer is intended to facilitate proper insertion and placement of the cannula within the vessel for extracorporeal circulatory support. These devices are to be used by a trained physician only.
Product codes (comma separated list FDA assigned to the subject device)
DWF
Device Description
The TandemHeart Femoral Arterial Cannula Set consists of two components, as shown in Figure 1: a 17 Fr. Femoral Arterial Cannula and a 12 Fr. Introducer. The device is intended to cannulate vessels, perfuse vessels or organs, and/or connect with accessory extracorporeal circulatory support equipment. The product is intended to be single patient, single use, sterile device.
The cannula has multiple side holes in addition to the tip opening for unimpeded flow of blood at the distal end and a vented barbed fitting at the proximal end to enable the connection of 3/8" tubing. Radiopaque markers are embedded at the distal tip of the cannula, and the cannula body is wire-reinforced for visualization under fluoroscopy. Insertion depth markings have been incorporated in the cannula body working length from 5 to 17 cm measured from the distal tip.
The cannula includes a suture wing to provide a means for securing the cannula to the patient and a stop component to minimize cannula insertion depth beyond its working length. Printing on the proximal region of the cannula indicates the area where a clamp should be applied if needed during the set-up or removal process.
The 12 Fr. introducer is provided to facilitate placement of the arterial cannula, within the target vessel, and is designed with a tapered distal tip. The introducer proximal end contains a luer hub to aid in the removal of the introducer. The introducer body is also constructed of a radiopaque material for visualization under fluoroscopy.
The introducer includes a hemostasis cap that provides the interface between the cannula proximal connector and introducer body. The hemostasis cap aids in minimizing blood loss during the insertion of the cannula/introducer assembly into the target vessel.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
vessels
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical performance testing was performed to demonstrate substantial equivalence. The performance testing included in-vitro hemolysis testing, in-vitro system capacity testing, flow vs. pressure drop (HQ), kink testing, leak testing, and deflection testing. All performance tests were conducted on both the TandemHeart Femoral Arterial Cannula Set and the predicate Medtronic Bio-Medicus Femoral Cannula and Introducer. Based on the performance test results, the TandemHeart Femoral Cannula Set was found to meet the established design input requirements as well as perform substantially equivalent to the predicate Medtronic Bio-Medicus Femoral Cannula and Introducer.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.4210 Cardiopulmonary bypass vascular catheter, cannula, or tubing.
(a)
Identification. A cardiopulmonary bypass vascular catheter, cannula, or tubing is a device used in cardiopulmonary surgery to cannulate the vessels, perfuse the coronary arteries, and to interconnect the catheters and cannulas with an oxygenator. The device includes accessory bypass equipment.(b)
Classification. Class II (performance standards).
0
MAY 3 0 2012
510(k) Summary
Date: May 17, 2012
Applicant
CardiacAssist. Inc. 240 Alpha Drive Pittsburgh, PA 15238 Telephone: 412-963-7770 Fax: 412-963-0800
Contact person
Katie Dillon Title: Regulatory Affairs Manager Phone: 412-963-7770 x266 e-mail: kdillon@cardiacassist.com
Device
| Trade/Proprietary Name: | TandemHeart Femoral Arterial Cannula Set |
|---|---|
| Common Name: | Femoral Arterial Cannula and Introducer |
| Classification Name: | Cardiopulmonary bypass vascular catheter, cannula, or |
| tubing. (21 CFR 870.4210. Product Code DWF) |
Predicate Device
Medtronic Bio-Medicus Femoral Cannula and Introducer (K924642)
Device Description
The TandemHeart Femoral Arterial Cannula Set consists of two components, as shown in Figure 1: a 17 Fr. Femoral Arterial Cannula and a 12 Fr. Introducer. The device is intended to cannulate vessels, perfuse vessels or organs, and/or connect with accessory extracorporeal circulatory support equipment. The product is intended to be single patient, single use, sterile device.
The cannula has multiple side holes in addition to the tip opening for unimpeded flow of blood at the distal end and a vented barbed fitting at the proximal end to enable the connection of 3/8" tubing. Radiopaque markers are embedded at the distal tip of the cannula, and the cannula body is wire-reinforced for visualization under fluoroscopy. Insertion depth markings have been incorporated in the cannula body working length from 5 to 17 cm measured from the distal tip.
1
The cannula includes a suture wing to provide a means for securing the cannula to the patient and a stop component to minimize cannula insertion depth beyond its working length. Printing on the proximal region of the cannula indicates the area where a clamp should be applied if needed during the set-up or removal process.
The 12 Fr. introducer is provided to facilitate placement of the arterial cannula, within the target vessel, and is designed with a tapered distal tip. The introducer proximal end contains a luer hub to aid in the removal of the introducer. The introducer body is also constructed of a radiopaque material for visualization under fluoroscopy.
The introducer includes a hemostasis cap that provides the interface between the cannula proximal connector and introducer body. The hemostasis cap aids in minimizing blood loss during the insertion of the cannula/introducer assembly into the target vessel.
Image /page/1/Figure/4 description: The image shows a diagram of a 17 Fr TandemHeart Femoral Arterial Cannula and a 12 Fr Introducer. The cannula has several labeled parts, including a clamp area, vented barbed connector, suture wing, stop, insertion depth markers, and a wire-reinforced area. The introducer has an introducer hub with a luer and a hemostasis cap, and the cannula tip has radiopaque discs.
Figure 1: TandemHeart Femoral Arterial Cannula Set
Intended Use
The Femoral Arterial Cannula and Introducer Set is intended to cannulate vessels, perfuse vessels or organs and/or connect with accessory extracorporeal circulatory support equipment for a duration of six hours or less. The cannula introducer is intended to facilitate proper insertion and placement of the cannula within the vessel for extracorporeal circulatory support. These devices are to be used by a trained physician only.
2
Comparison of Technological Characteristics
The TandemHeart Femoral Arterial Cannula Set and the predicate Medtronic Bio-Medicus Femoral Cannula and Introducer have the same intended use and both consist of a wire-reinforced, polyurethane arterial cannula and a polyurethane introducer. The TandemHeart Femoral Arterial Cannula Set contains two additional components located on the exterior proximal portion of the cannula: a suture wing to provide a means of securing the cannula to the patient and a stop component to minimize insertion of the cannula beyond its working length. The suture wing and stop component are constructed of soft durometer Tecoflex polyurethane, a commonly used material for interventional medical devices. and were tested for biocompatibility. The TandemHeart Femoral Arterial Cannula Set's cannula includes a distal tip taper, while the predicate has a straight tip. The TandemHeart Arterial cannula also has fewer side holes than the predicate device.
Performance Data
Non-clinical performance testing was performed to demonstrate substantial equivalence. The performance testing included in-vitro hemolysis testing, in-vitro system capacity testing, flow vs. pressure drop (HQ), kink testing, leak testing, and deflection testing. All performance tests were conducted on both the TandemHeart Femoral Arterial Cannula Set and the predicate Medtronic Bio-Medicus Femoral Cannula and Introducer. Based on the performance test results, the TandemHeart Femoral Cannula Set was found to meet the established design input requirements as well as perform substantially equivalent to the predicate Medtronic Bio-Medicus Femoral Cannula and Introducer.
Conclusions
The TandemHeart Femoral Arterial Cannula Set is substantially equivalent to the Medtronic Bio-Medicus Femoral Cannula and Introducer in design characteristics, performance, and intended use. The performance testing demonstrated that despite the geometric differences, including a distal tip taper on the TandemHeart device and fewer side holes than the predicate device, the TandemHeart Femoral Arterial Cannula Set performed substantially equivalent to the predicate device. The two additional components on the TandemHeart Femoral Arterial Cannula Set's cannula body, the suture wing and stop, were found to be biocompatible.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
MAY 3 0 2012
CardiacAssist, Inc. c/o Ms. Katie Dillon Regulatory Affairs Specialist 240 Alpha Drive Pittsburgh, PA 15238
Re: K120543
Trade/Device Name: TandemHeart Femoral Arterial Cannula Set Regulation Number: 21 CFR 870.4210 Regulation Name: Cardiopulmonary bypass vascular catheter, cannula, or tubing Regulatory Class: Class II Product Code: DWF Dated: May 17, 2012 Received: May 18, 2012
Dear Ms. Dillon:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 – Mr. Katie Dillon
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Cm A. Killeber
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number: K120543
Device Name: TandemHeart Femoral Arterial Cannula Set
Indications for Use:
The Femoral Arterial Cannula and Introducer is intended to cannulate vessels, perfuse vessels or organs and/or connect with accessory extracorporeal circulatory support equipment for a duration of six hours or less. The cannula introducer is intended to facilitate proper insertion and placement of the cannula within the vessel for extracorporeal circulatory support. These devices are to be used by a trained physician only.
Prescription Use X (Part 21 CFR 801 Subpart D)
Over-The-Counter Use AND/OR (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
MG. Stilleben
n Sian-Off) Division of Cardiovascular Devices
K120543 510(k) Number_